-
公开(公告)号:US20220185838A1
公开(公告)日:2022-06-16
申请号:US17538752
申请日:2021-11-30
Applicant: UNIVERSITÄT BASEL
Inventor: Beat Ernst , Ruben Herrendorff , Andreas Steck , Fan Yang
IPC: C07H15/207 , C07H15/203 , C08G69/10 , C08G69/48 , G01N33/68 , C08F2/00 , C08F120/36
Abstract: The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.
-
公开(公告)号:US11220523B2
公开(公告)日:2022-01-11
申请号:US16848268
申请日:2020-04-14
Applicant: UNIVERSITÄT BASEL
Inventor: Beat Ernst , Ruben Herrendorff , Andreas Steck , Fan Yang
IPC: C07H15/203 , C07H15/207 , C08G69/10 , C08G69/48 , G01N33/68 , C08F2/00 , C08F120/36
Abstract: The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.
-
公开(公告)号:US10662212B2
公开(公告)日:2020-05-26
申请号:US15977422
申请日:2018-05-11
Applicant: UNIVERSITÄT BASEL
Inventor: Beat Ernst , Ruben Herrendorff , Andreas Steck , Fan Yang
IPC: C07H15/207 , C07H15/203 , C08G69/10 , C08G69/48 , G01N33/68 , C08F2/00 , C08F120/36
Abstract: The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substitutents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.
-
公开(公告)号:US11091591B2
公开(公告)日:2021-08-17
申请号:US15760398
申请日:2016-09-14
Applicant: UNIVERSITÄT BASEL
Inventor: Ruben Herrendorff , Beat Ernst , Andreas Steck , Hélène Pfister , Giulio Navarra
Abstract: The invention relates to carbohydrate ligands and moieties, respectively, mimicking glycoepitopes comprised by glycosphingolipids of the nervous system, particularly glycoepitopes comprised by glycosphingolipids of the cerebroside, the globoside-, the ganglioside- and the sulfoglucuronyl paragloboside type, which are bound by anti-glycan antibodies associated with neurological diseases. The invention further relates to the use of these carbohydrate ligands/moieties, in diagnosis as well as for the treatment of neurological diseases associated with anti-glycan antibodies. In particular, the invention relates to compounds of formula (I) and (II) and to therapeutically acceptable polymers comprising a multitude of these compounds, including polymers with loading of one compound of formula (I) or (II) or combinations of several compounds of formula (I), and/or (II). The compounds of formula (I) are defined as: wherein RI1 is Z or wherein RI2 is H, SO3H, or wherein RI3 is H or wherein RI4 is H or wherein RI5 and RI6 are independently H or wherein RI7 is H or and compounds of formula (II) are defined as: wherein RII1 is Z or wherein RII2 is Z or wherein Z is —N(Ra)—A—B—CH2—(CH2)q—SH, wherein Ra is H, C1-C4-alky, C1-C4alkoxy, CH2C6H5, CH2CH2C6H5, OCH2C6H5, or OCH2CH2C6H5; A is C1-C7-alkylene, C1-C7-alkoxy, C1-C4-alkyl—(OCH2CH2)pO—C1-C4-alkyl, or C1-C7-alkoxy-Rb, wherein Rb is an optionally substituted aryl or an optionally substituted heteroaryl, and wherein p is 0 to 6, preferably p is 1, 2 or 3, and further preferably p is 1; B is NHC(O), S or CH2; q is 0 to 6, preferably q is 1, 2, 3 or 4, and further preferably q is 1 or 2.
-
公开(公告)号:US20210061838A1
公开(公告)日:2021-03-04
申请号:US16848268
申请日:2020-04-14
Applicant: UNIVERSITÄT BASEL
Inventor: Beat Ernst , Ruben Herrendorff , Andreas Steck , Fan Yang
IPC: C07H15/207 , C07H15/203 , C08G69/10 , C08G69/48 , G01N33/68 , C08F2/00 , C08F120/36
Abstract: The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of anti-MAG neuropathy. In particular, the invention relates to disaccharides of formula (I) and (II) wherein Z is optionally substituted phenyl, heteroaryl, arylcarbonyl, or heteroarylmethyl, and to therapeutically acceptable polymers comprising a multitude of substituents of formula (I) and/or formula (II), wherein Z is a bifunctional linker connecting the disaccharides to the polymer backbone.
-
-
-
-